210 related articles for article (PubMed ID: 30791892)
21. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
22. Factors Predicting Fecal Occult Blood Testing among Residents of Bushehr, Iran, Based on the Health Belief Model.
Ghobadi Dashdebi K; Noroozi A; Tahmasebi R
Asian Pac J Cancer Prev; 2016; 17(S3):17-22. PubMed ID: 27165201
[TBL] [Abstract][Full Text] [Related]
23. Discrepancies and misconceptions of perceived colorectal cancer screening barriers between primary health professionals and unscreened population. A comparative study in Greece.
Mastrokostas A; Gavana M; Gkrizioti M; Smyrnakis E; Cholongitas E; Benos A; Haidich AB
J BUON; 2018 Dec; 23(7):67-76. PubMed ID: 30722114
[TBL] [Abstract][Full Text] [Related]
24. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
Spaeth A; Zwahlen M
Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
[TBL] [Abstract][Full Text] [Related]
25. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with patients' decision on colorectal cancer screening.
Chuang YM; Han SQ; Tseng CC; Tseng CF; Hu YJ
Medicine (Baltimore); 2021 Aug; 100(31):e26735. PubMed ID: 34397813
[TBL] [Abstract][Full Text] [Related]
27. Cancer screening beliefs and reactions to an innovative colorectal cancer screening kit among Chinese worksite population.
Hou S; Chen P
Methods Inf Med; 2005; 44(2):315-8. PubMed ID: 15924199
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
[TBL] [Abstract][Full Text] [Related]
29. Factors of Never Screened with Faecal Occult Blood Test in Public Primary Care Facilities.
Sazali MF; Syed Abdul Rahim SS; Avoi R; Hassan MR; Hayati F; Azhar ZI; Jeffree MS; Awang Lukman K; Oo Tha N; Sajali H; Atil A; Abd Rahim MA
Asian Pac J Cancer Prev; 2021 Jan; 22(1):163-169. PubMed ID: 33507695
[TBL] [Abstract][Full Text] [Related]
30. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
31. An Out-of-Pocket Cost Removal Intervention on Fecal Occult Blood Test Attendance.
Tabuchi T; Murayama H; Hoshino T; Nakayama T
Am J Prev Med; 2017 Aug; 53(2):e51-e62. PubMed ID: 28236518
[TBL] [Abstract][Full Text] [Related]
32. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
33. Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006-2013).
Rim JH; Youk T; Kang JG; Park BK; Gee HY; Kim JH; Yoo J
Sci Rep; 2017 Jun; 7(1):2804. PubMed ID: 28584248
[TBL] [Abstract][Full Text] [Related]
34. Examining the Factors That Affect the Diagnosis of Patients with Positive Fecal Occult Blood Test Results.
Cheng YW; Li YC
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805251
[TBL] [Abstract][Full Text] [Related]
35. Psychometric Evaluation of the Colorectal Cancer Screening Belief Scale Based on Health Belief Model's Constructs for the Fecal Occult Blood Test.
Tahmasebi R; Noroozi A; Dashdebi KG
Asian Pac J Cancer Prev; 2016; 17(1):225-9. PubMed ID: 26838214
[TBL] [Abstract][Full Text] [Related]
36. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
[TBL] [Abstract][Full Text] [Related]
37. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.
Collins JF; Lieberman DA; Durbin TE; Weiss DG;
Ann Intern Med; 2005 Jan; 142(2):81-5. PubMed ID: 15657155
[TBL] [Abstract][Full Text] [Related]
39. Utilization of fecal occult blood test in the acute hospital setting and its impact on clinical management and outcomes.
Mosadeghi S; Ren H; Catungal J; Yen I; Liu B; Wong RJ; Bhuket T
J Postgrad Med; 2016; 62(2):91-5. PubMed ID: 27089107
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
Dodd N; Mansfield E; Carey M; Oldmeadow C
Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
